Open AccessInterleukin-6 and body mass index, tobacco use, and sleep in gynecologic cancers.
Author(s) -
Elizabeth L. Kacel,
Janae L. Kirsch,
Timothy S. Sannes,
Seema M. Patidar,
Rachel Postupack,
Sally E. Jensen,
Shan S. Wong,
Stephanie Garey,
Stacy M. Dodd,
Chantel Ulfig,
Christina S. McCrae,
Michael E. Robinson,
Jacqueline Castagno,
Gregory S. Schultz,
Deidre Pereira
Publication year - 2019
Publication title -
health psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.548
H-Index - 164
eISSN - 1930-7810
pISSN - 0278-6133
DOI - 10.1037/hea0000775
Subject(s) - body mass index , medicine , sleep (system call) , tobacco use , oncology , environmental health , population , computer science , operating system
Elevated body mass index (BMI), tobacco use, and sleep disturbance are common health concerns among women with gynecologic cancers. The extent to which these factors are associated with systemic inflammation in gynecologic cancers is unknown. This is a significant literature gap given that (a) chronic, systemic inflammation may mediate relationships between behavioral health factors and cancer outcomes; and (b) elevated BMI, tobacco use, and sleep disturbances can be modified via behavioral interventions. This study examined Interleukin-6 (IL-6) relations with BMI, tobacco use history, and sleep disturbances in patients undergoing surgery for suspected gynecologic cancer.